Compound 509
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N1CCCCC1
- IUPAC name:
3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[[4-(piperidine-1-carbonyl)phenyl]methyl]benzenesulfonamide
- InChi:
InChI=1S/C26H25Cl2FN2O4S/c27-21-14-23(28)25(32)24(15-21)36(34,35)31(17-19-6-10-22(29)11-7-19)16-18-4-8-20(9-5-18)26(33)30-12-2-1-3-13-30/h4-11,14-15,32H,1-3,12-13,16-17H2
- InChiKey:
NJCCLEHEQAKZSF-UHFFFAOYSA-N
External links
58531604 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 130 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.08 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 550.09 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.67 | |||
TPSA | 77.92 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 130 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.08 | |
WO2009152082 | 130 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.69 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5633 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.5440 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.5241 | Glyburide | DB01016 | |
0.5108 | Avagacestat | DB11893 | |
0.5087 | ABT-639 | DB15055 | |
0.5040 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.5039 | 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide | DB03697 | |
0.5027 | Repinotan | DB06506 | |
0.5000 | Sp-722 | DB04503 | |
0.5000 | Clorexolone | DB13617 | |
0.4886 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 | |
0.4886 | 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide | DB02861 | |
0.4886 | Saccharin | DB12418 | |
0.4886 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide | DB02221 | |
0.4848 | 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide | DB04002 |